What are the considerations for managing a skin abscess that has not improved after two days of oral cephalexin (Keflex) and has been incised and drained?

Management of Skin Abscess After Failed Cephalexin and I&D

Switch to an antibiotic with MRSA coverage (trimethoprim-sulfamethoxazole, doxycycline, or clindamycin) and obtain wound cultures to guide further therapy. The failure to improve on cephalexin after two days strongly suggests methicillin-resistant Staphylococcus aureus (MRSA) as the causative organism, which is now the predominant pathogen in community-acquired skin abscesses.

Key Considerations

Why Cephalexin Failed

The IDSA guidelines explicitly state that first-generation cephalosporins like cephalexin are "usually effective as most staphylococcal isolates from impetigo and ecthyma are methicillin susceptible" 1. However, this guidance does not apply well to abscesses in the current epidemiologic context. Research demonstrates that 87.8% of S. aureus isolates from skin abscesses are MRSA 2, and cephalexin has no activity against MRSA 3. The lack of clinical improvement after 48 hours of cephalexin therapy in a properly drained abscess is a red flag for MRSA infection.

Immediate Management Steps

1. Obtain wound cultures now if not already done

• The IDSA guidelines recommend Gram stain and culture of pus from abscesses, though treatment without these studies is reasonable in typical cases 1
• Given treatment failure, cultures are now essential to identify the pathogen and guide antibiotic selection
• Culture results will confirm MRSA and provide susceptibility data

2. Switch to MRSA-active antibiotics immediately

• The IDSA guidelines specifically recommend antibiotics active against MRSA for patients with systemic inflammatory response syndrome (SIRS) or marked immunocompromise 1
• Recommended MRSA-active agents include:
  • Trimethoprim-sulfamethoxazole (TMP-SMX): Most evidence-based choice
  • Doxycycline: Alternative option
  • Clindamycin: Use if local resistance rates are acceptable (<10-15%)

Evidence Supporting MRSA-Active Antibiotics

Recent high-quality evidence demonstrates significant benefit from MRSA-active antibiotics after I&D:

• TMP-SMX showed superior outcomes with clinical cure rates of 92.9% versus 85.7% for placebo at 7-14 days, and composite cure rates of 86.5% versus 74.3% 4
• A 2019 meta-analysis found antibiotics after I&D resulted in increased clinical cure rates (odds ratio 2.32,95% CI 1.75-3.08) and decreased new lesion formation 5
• Treatment effect was greatest in patients with history of MRSA infection, fever, and positive MRSA cultures 4

Reassess the Adequacy of I&D

Verify that drainage was complete:

• Inadequate drainage is the most common reason for treatment failure, even more than antibiotic choice
• Look for:
  • Persistent fluctuance suggesting undrained pockets
  • Loculations requiring additional drainage
  • Foreign material (consider pilonidal cyst, hidradenitis suppurativa) 1
• If drainage was inadequate, repeat I&D is more important than changing antibiotics

When to Consider Antibiotics May Not Be Needed

The IDSA guidelines state that systemic antimicrobials are usually unnecessary after I&D unless fever or other evidence of systemic infection is present 1. One study showed 90.5% cure rates with I&D alone (no antibiotics) 2. However, this patient already failed initial management, so antibiotics are now indicated.

Assess for Indications Requiring MRSA-Active Antibiotics

Check for SIRS criteria (any of the following):

• Temperature >38°C or <36°C
• Tachypnea >24 breaths/minute
• Tachycardia >90 beats/minute
• WBC >12,000 or <4,000 cells/µL

Check for high-risk features:

• Immunocompromise (diabetes, HIV, immunosuppressive medications)
• Multiple abscesses or surrounding cellulitis
• Failed initial therapy (this patient)
• Previous MRSA infection

If any of these are present, MRSA-active antibiotics are strongly indicated 1.

Recommended Treatment Protocol

Antibiotic choice (pick one):

• TMP-SMX 1-2 double-strength tablets (160/800 mg) twice daily for 5-10 days 4
• Doxycycline 100 mg twice daily for 5-10 days
• Clindamycin 300-450 mg three times daily for 5-10 days (if local MRSA resistance <15%)

Duration: 5-10 days is appropriate for uncomplicated abscesses after adequate drainage 1, 6

Follow-up: Reassess in 48-72 hours to confirm clinical improvement

Common Pitfalls to Avoid

1. Continuing cephalexin despite treatment failure - This is ineffective against MRSA and delays appropriate therapy
2. Assuming adequate drainage without verification - Repeat examination for fluctuance; re-drain if needed
3. Using clindamycin without knowing local resistance patterns - Many areas have >15% clindamycin-resistant MRSA
4. Prescribing unnecessarily long antibiotic courses - 5-7 days is usually sufficient after adequate drainage 6
5. Not obtaining cultures in treatment failures - Cultures are critical when initial therapy fails 1

Special Considerations for Recurrent Abscesses

If this represents a recurrent abscess at the same site, search for:

• Pilonidal cyst
• Hidradenitis suppurativa
• Retained foreign material 1

Consider decolonization if recurrent infections occur:

• Intranasal mupirocin twice daily for 5 days
• Daily chlorhexidine washes
• Decontamination of personal items 1